Exact Mass: 583.1245

Exact Mass Matches: 583.1245

Found 13 metabolites which its exact mass value is equals to given mass value 583.1245, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fostemsavir

({3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl}methoxy)phosphonic acid

C25H26N7O8P (583.158)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D065147 - Viral Fusion Protein Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D065147 - Viral Fusion Protein Inhibitors > D023581 - HIV Fusion Inhibitors

   
   
   

25-hydroxy-24-oxokibdelone C

25-hydroxy-24-oxokibdelone C

C29H29NO12 (583.169)


   

3-sinapoyloxypropylglucosinolate

3-sinapoyloxypropylglucosinolate

C21H29NO14S2 (583.1029)


   

7-(4-{[3-(2,6-Difluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}- 1-piperazinyl)-6-nitro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-c arboxylic acid

7-(4-{[3-(2,6-Difluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}- 1-piperazinyl)-6-nitro-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-c arboxylic acid

C26H19F2N5O7S (583.0973)


   

Nilotinib hydrochloride monohydrate

Nilotinib monohydrochloride monohydrate

C28H25ClF3N7O2 (583.171)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor

   

methyl (phenyl 5-acetamido-4,7,8,9-tetra-o-acetyl-3,5-dideoxy-2-thio-d-glycero-d-galacto-2-nonulopyranosid)onate

methyl (phenyl 5-acetamido-4,7,8,9-tetra-o-acetyl-3,5-dideoxy-2-thio-d-glycero-d-galacto-2-nonulopyranosid)onate

C26H33NO12S (583.1723)


   

Fostemsavir

Fostemsavir

C25H26N7O8P (583.158)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D065147 - Viral Fusion Protein Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D065147 - Viral Fusion Protein Inhibitors > D023581 - HIV Fusion Inhibitors

   

2-O-(beta-D-mannosyl)-bis(myo-inositol) 1,3-phosphate

2-O-(beta-D-mannosyl)-bis(myo-inositol) 1,3-phosphate

C18H32O19P- (583.1275)


   

[(4E)-4-sulfooxyimino-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbutyl] (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

[(4E)-4-sulfooxyimino-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbutyl] (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

C21H29NO14S2 (583.1029)


   

AZD-8529 (mesylate)

AZD-8529 (mesylate)

C25H28F3N5O6S (583.1712)


AZD-8529 mesylate is a potent, highly selective and orally bioavailable positive allosteric modulator of mGluR2, with an EC50 of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes[1].

   

(10s,12s,13r)-4-chloro-10,12,13,15-tetrahydroxy-8-methoxy-2-methyl-3-propyl-6,7,10,11,12,13-hexahydro-9-oxa-2-azahexaphene-1,5,14,16-tetrone

(10s,12s,13r)-4-chloro-10,12,13,15-tetrahydroxy-8-methoxy-2-methyl-3-propyl-6,7,10,11,12,13-hexahydro-9-oxa-2-azahexaphene-1,5,14,16-tetrone

C29H26ClNO10 (583.1245)